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ABSTRACT 23 
The aim on this study was to determine whether the prophylactic use of antibiotics in 24 
the placement of intravaginal sponges for estrus synchronization in caprine may be the 25 
cause of the presence of inhibitors in milk and, therefore, of positive results in the 26 
microbial screening tests. Ninety-eight Murciano-Granadina goats divided into 7 groups 27 
of 14 animals were used. Intravaginal sponges were placed in 6 groups using two 28 
concentrations of different commercial antibiotics: doxycycline (Hipradoxi®), 29 
oxytetracycline (Terramycin®) and sulfathiazhole-framycetin (Framicas®). The sponges 30 
of the control group were placed without antibiotics. Milk samples were collected daily 31 
along the 7-day-post-treatment and analyzed by three microbial tests (BRT MRL, 32 
Delvotest SP-NT MCS and Eclipse 100). Positive samples were retested by specific 33 
receptor-binding assays (SNAP Tetracycline and Sulfasensor tests) to confirm the non-34 
compliant results. The vagina status was evaluated through the visual assessment of the 35 
sponge external aspect after removal. Results indicate that the microbial test response 36 
was unaffected by neither the day post-treatment nor the dose of antibiotic used, except 37 
for oxytetracycline at highest concentration. Moreover, no positive results were 38 
obtained using receptor-binding assays suggesting that residues, if present in milk, not 39 
exceed the safety levels established for these drugs in the legislation. The occurrence of 40 
soiled sponges was higher in the control group. Respect to the dose of antibiotics used 41 
no significant differences were obtained for the lowest dose administered. However, a 42 
significant increase in the percentage of clean sponges was observed for the highest 43 
dose of doxycycline. It can be concluded that the prophylactic use of low amounts of 44 
doxycycline, oxitetracycline and sulfathiazole in the synchronization of estrus by 45 
intravaginal sponges contributes to reduce the clinical vaginitis in dairy goats and does 46 
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not seem to be the cause of positive results in microbial inhibitor tests used to detect 47 
antibiotics in goat milk.  48 
Key words: goat milk, intravaginal sponge, antibiotic screening methods. 49 
SHORT COMMUNICATION 50 
Intravaginal sponges impregnated with progesterone or synthetic progestogens during 6-51 
16 days before the artificial insemination are usually employed for oestrus 52 
synchronization in goats (Menchaca and Rubianes, 2004; Rowe et al., 2009). However, 53 
this practice has been related to the occurrence of clinical vaginitis in goats (Motlomelo 54 
et al., 2004; Penna et al., 2003), which could negatively affect the fertility rates reached 55 
on farms (Scudemore, 1988). 56 
To avoid these negative effects, some authors recommend to sprinkle the sponges with 57 
antibiotics prior to its insertion into the vagina (Guerra et al., 2002; Suarez et al., 2006; 58 
Gatti et al., 2011), oxytetracycline being the drug commonly used for this purpose in 59 
practice (Manes et al., 2013). 60 
It should be noted that the prophylactic use of antibiotics in the placement of 61 
intravaginal sponges is an unregulated reproductive management on which there are no 62 
recommendations approved with regard to the dose and the withdrawal period required 63 
to avoid the presence of drug residues in milk. In caprine, the synchronization of estrus 64 
by intravaginal sponges takes place during lactation and, therefore, the inclusion of 65 
antibiotics to sprinkle them may pose a risk of contamination in milk. Thus, some 66 
authors have found antibiotic residues in cow milk 24-48 hours after the intrauterine 67 
administration of suppositories, infusions and tablets of penicillin, streptomycin, and 68 
tetracycline (Miller and Bergt, 1974; Black et al., 1979; Bishop et al., 1984). In ewes, 69 
drug residues in milk after the inclusion of intravaginal sponges impregnated with 70 
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benzylpenicillin procaine were evaluated by Berruga et al. (2008), by using different 71 
microbial inhibitor tests for screening antibiotics. Positive and doubtful results were 72 
obtained at the time of the first milking and, sometimes, afterwards due to the presence 73 
of drug residues in milk. In dairy goats, related information is rather limited. 74 
Microbial inhibitor tests are widely used for screening antibiotics in milk above 75 
maximum residue limits (MRLs) established by legislation (Commission Regulation UE 76 
Nº 37/2010). The performance of these screening tests (specificity and detection 77 
capability) allows the detection of a large number of substances in milk at or below 78 
MRLs to guarantee the safety of milk and related products. 79 
Thus, the aim of this study was to evaluate whether the prophylactic use of antibiotics in 80 
the synchronization of estrus by intravaginal sponges in caprine may be the cause of the 81 
presence of inhibitors in milk and, therefore, of positive results in the microbial 82 
screening tests. 83 
Experimental animal procedures were approved by the Ethics Committee of Universitat 84 
Politècnica de València (UPV, Valencia, Spain). Ninety-eight Murciano-Granadina 85 
goats in the fourth month of lactation, from the herd of Diputación de Castellón de la 86 
Plana (Ares del Maestrat, Spain) were used. The animals were healthy and did not 87 
receive any drug treatment prior to the experiment. 88 
Goats were randomly divided into seven groups of 14 animals. A polyurethane sponge 89 
containing 30 mg of flugestone acetate (Sincropart, Ceva Salud Animal, Barcelona, 90 
Spain) was inserted into the vagina along 11-day period. Prior the insertion, the sponges 91 
were impregnated with two concentrations of three veterinary drugs usually applied in 92 
dairy goats: doxycycline (Hipradoxi®, Laboratorios Hipra, S.A., Gerona, Spain), 93 
oxytetracycline (Terramycin®, Pfizer S.L.U., Madrid, Spain) and sulfathiazole (96%) 94 
and framicetin 4% (Framicas®, Laboratorios Ovejero S.A., León Spain). In agreement 95 
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with the veterinary practice, antibiotics were added into the bag containing 25 sponges 96 
and mixed by shaking. In the control group the sponges did not contain any antibiotic. 97 
Two different doses of antibiotics were used: Dose 1 equivalent to 1g of commercial 98 
product corresponding to a concentration of active principle for doxycycline of 100 mg, 99 
for oxytetracycline of 550 mg and for sulfathiazole of 960 mg, and Dose 2= 2 g 100 
equivalent to twice the amount of active compound of Dose 1. 101 
According to the estrus synchronization by hormonal treatment, on the 9th day from the 102 
placement of intravaginal sponge an i.m. administration of 300 IU of equine chorionic 103 
gonadotropin (Sincropart PMSG, Ceva Salud Animal, Barcelona, Spain) and 0.5 mL of 104 
Enzaprost (synthetic analog of PGF2α, Ceva Salud Animal) were applied. The vagina 105 
status was evaluated through the visual assessment of the sponge external aspect after 106 
removal. Sponges were classified as follows: 0= clean sponge (without bloody, purulent 107 
or foul-smelling discharges), 1= soiled sponge (presence of bloody secretions, vaginal 108 
mucus but no abnormal odor), and 2= very soiled sponge (presence of bloody 109 
secretions, high quantity of vaginal mucus and foul odor). 110 
The animals were milked once a day (07:00 h) in a milking parlour and during the 7 111 
days after the sponge insertion, individual goat milk samples (100 mL) were collected 112 
and transported in refrigeration (< 10 ºC) to the laboratories of the Universitat 113 
Politècnica de València. 114 
Milk samples were analyzed in triplicate by microbial inhibitor tests: BRT MRL (AiM 115 
Analytik in MilchProduktions-und Vertriebs-GmbH, Munich, Germany), Delvotest SP-116 
NT MCS (DSM Food Specialties, Delft, the Netherlands) and Eclipse 100 (ZEULAB 117 
S.L., Zaragoza, Spain) according to the manufacturer’s instructions. In all cases, 118 
negative (antimicrobial-free milk) and positive (milk spiked with 4 µgkg-1 of 119 
benzylpenicillin) controls were included in each test. Interpretation of the test results 120 
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was carried out independently by three trained technicians assessing visually the colour 121 
change after incubation, and classifying milk samples as positive (blue) or negative 122 
(yellow). Positive samples were retested by specific receptor-binding assays for 123 
tetracycline (SNAP Tetracycline test, IDEXX laboratories, Westbrook, ME) and for 124 
sulfonamides (Sulfasensor test, Unisensor, Liege, Belgium) following the 125 
manufacturer’s instructions. The test results were classified as positive or negative by 126 
instrumental readers (SNAP shot reader, IDEXX laboratories and Readsensor, 127 
Unisensor). 128 
The detection limits (DLs) of microbial inhibitor tests for doxycycline, oxytetracycline 129 
and sulfathiazole were calculated according to the IDF recommendations (IDF, 2003) 130 
and summarized in Table 1. The DLs of the receptor-binding assays provided by the 131 
manufacturers were also included (Table1). 132 
A logistic regression model was applied to evaluate both the effect of the dose of 133 
antibiotic employed as the days after treatment on the occurrence of positive outcomes 134 
in the microbial screening tests. 135 
Lijk = Logit [P ijk] + β0 + β1 [PD]i + β2 D1 +  β3 D2 + εijk 136 
Where: Lijk= Logit model; [Pijk]= probability for the response category (positive or 137 
negative); β0= intercept; β1, β2, β3= parameters estimated for the model; [PD]i= effect of 138 
the days post-treatment (n=7); D1 and D2= effect of dose 1 and dose 2, respectively, in 139 
dummy variable (without antibiotic: D1= 0 and D2= 0; dose 1: D1= 1 and D2= 0; dose 140 
2: D1= 0 and D2= 1); εijk = residual error 141 
To evaluate the status of the sponges as indicator of the antibiotic’s effectiveness to 142 
prevent clinical vaginitis, the χ2-test was applied. Statistical analyses were performed 143 
using SAS (version 9.2. 2001; SAS Institute Inc. Cary, NC).  144 
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Table 2 shows the positive results obtained in the microbial inhibitor tests during the 145 
first week after treatment. In general, the microbial test response was unaffected by the 146 
dose of antibiotic added to intravaginal sponges (P > 0.05). Thus, the occurrence of 147 
positive results in milk from goats belonging to the control group was similar to that 148 
obtained for milk from goats treated with antibiotics. Only for the highest dose of 149 
oxytetracycline (2g/25 sponges) a significant increase (P < 0.05) of positive results in 150 
the BRT MRL test was observed. Nor significant differences along the 7 days-post-151 
treatment were found (P > 0.05). The results obtained herein differ from those reported 152 
by Berruga et al. (2008), who using intravaginal sponges impregnated with a drug that 153 
combines benzylpenicillin procaine and DH-streptomycin in ovine, indicated the 154 
highest occurrence of positive results in the first milking after treatment. 155 
No positive results were obtained when milk samples were retested by specific receptor-156 
binding assays, suggesting that drug residues, if present in milk, are below the DLs of 157 
these tests, not exceeding the MRLs established for these drugs in the legislation. 158 
Therefore, positive outcomes in the microbial inhibitor tests herein may be related to the 159 
performance of these unspecific tests that can be affected by several factors related to 160 
the milk composition leading to non-compliant results in milk free of antibiotics. Thus, 161 
the percentage of positive results obtained in this study are similar to the false-positive 162 
rate reported by Beltrán et al. (2015) for these microbial tests using individual goat’s 163 
milk samples (Delvotest SP-NT MCS: 3.1 %; Eclipse 100: 0.6 %) except for the BRT 164 
MRL test that was higher than that reported by these authors (6.1 vs 1.4 %). 165 
Regarding to the status of the vagina evaluated through the presence of bloody, purulent 166 
or foul-smelling discharges into sponges after removal (Figure 1), the occurrence of 167 
soiled sponges in the control group was higher (P < 0.05) than that obtained in the 168 
groups treated with antibiotics. Regarding to the dose of antibiotics used no significant 169 
 8 
differences were obtained for the lowest dose administered, showing similar 170 
percentages of soiled sponges (P > 0.05). However, for the highest concentrations, a 171 
significant increase in the percentage of clean sponges was observed, being doxycycline 172 
(Hipradoxi®) the most effective drug (P < 0.05) to protect the vaginal status. These 173 
results were in agreement to those reported by Manes et al. (2013) and Guerra et al. 174 
(2002) in goats, who also indicated that the inclusion of antibiotics prevent the vaginal 175 
infection caused by the use of intravaginal sponges. 176 
It can be concluded that the prophylactic use of low amounts of doxycycline, 177 
oxitetracycline, or sulfathiazole in the synchronization of estrus by intravaginal sponges 178 
contributes to reduce the incidence of clinical vaginitis in dairy goats and does not seem 179 
to be the cause of positive results in microbial inhibitor tests used to detect antibiotics in 180 
goat milk.  181 
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Table 1. Detection capability of microbial inhibitor tests and receptor-binding assays 235 
for the detection of antimicrobials in goat’s milk 236 
Methods 
Detection Limits (µg/kg) 
Doxycycline1 Oxytetracycline2 Sulfathiazole3 
Microbial inhibitor tests 
BRT MRL 135 124 48 
Delvotest SP-NT MCS 106 297 39 
Eclipse 100 113 134 47 
Receptor-binding assays4    
SNAP Tetracycline Test 305 ≥ 50 - 
Sulfasensor test - - 5-8 
1MRL not stablished, since it cannot use in animals from which milk is produced for human consumption; 237 
2MRL 100 µg/kg; 3MRL 100 µg/kg; 4data provided by manufacturers; 5Cross reactivity 100% of positive 238 














Table 2. Positive results in microbial inhibitor tests during the first week after the 252 
intravaginal sponge insertion in dairy goats 253 
Test Treatment 
Days after sponge insertion 
Total 
(%) 
1 2 3 4 5 6 7  
BRT MRL 
Control 0 2 1 1 2 0 0 6.1 
Doxycycline  
Dose 1 0 3 1 0 1 2 0 7.1 
Dose 2 0 2 2 0 1 2 0 7.1 
Oxitetracycline  
Dose 1 1 1 0 4 0 0 0 6.1 
Dose 2 3 2 3 3 3 0 0 14.3 
Sulfathiazole Dose 1 0 1 1 1 1 0 0 4.1 
Dose 2 1 1 0 0 0 0 1 3.1 
Delvotest     
SP-NT MCS 
Control 0 0 0 0 1 0 0 1 
Doxycycline  
Dose 1 0 0 0 0 0 0 0 0 
Dose 2 0 0 0 1 0 0 0 1 
Oxitetracycline  
Dose 1 0 1 0 0 0 0 0 1 
Dose 2 0 0 1 0 0 2 0 3.1 
Sulfathiazole Dose 1 0 0 1 0 0 0 0 1 
Dose 2 0 1 0 0 0 0 0 1 
Eclipse 100 
Control 0 0 1 0 0 0 0 1 
Doxycycline  
Dose 1 0 0 0 0 0 0 0 0 
Dose 2 0 0 0 0 0 0 0 0 
Oxitetracycline  
Dose 1 0 0 0 1 0 0 0 1 
Dose 2 0 0 0 1 0 0 0 1 
Sulfathiazole Dose 1 0 0 0 1 0 0 0 1 
Dose 2 0 0 0 0 0 0 0 0 
 254 
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Figure 1. Visual classification of the sponge status after removal according to the effectiveness 2 
of the different antibiotics and doses used (1 and 2) 3 
 4 
